Upfront : Actualité Upfront en direct - P1 | Bourse Reflex
Accueil > Tags > Upfront

  • Toutes les actualités en rapport avec « Upfront »

27/03 18:00 Upfront - Résultats annuels 2017

28/02 08:30 Upfront - GENTICEL ANNOUNCES ITS 2016 ANNUAL RESULTS

22/09 19:00 Upfront - GENTICEL PRESENTS FIRST HALF 2016 FINANCIAL RESULTS AND UPDATES ITS OPERATIONAL OUTLOOK

19/09 18:00 Upfront - SES-imagotag to acquire Pervasive Displays (PDi) in Taiwan and accelerate connected IoT e-paper label applications

14/03 07:00 Upfront - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

01/06 07:00 Upfront - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform

28/04 19:00 Upfront - Business Update - First Quarter 2015

02/03 19:00 Upfront - Résultats annuels 2014

02/03 19:00 Upfront - 2014 Annual Results

19/02 19:00 Upfront - Chiffre d'affaires au 4ème trimestre 2014

02/02 18:30 Upfront - Genticel licenses Vaxiclase platform to Serum Institute of India for use in pertussis vaccines

05/08 09:00 Upfront - Apricus Biosciences Provides Corporate Mid-Year Update

20/06 10:00 Upfront - Pluristem and United Therapeutics Enter Into an Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension

19/05 14:56 Upfront - Zoom sur une valeur: Stallergenes

10/05 15:55 Upfront - Apricus Biosciences Announces First Quarter 2011 Financial Results Conference Call

22/03 14:55 Upfront - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

08/03 16:00 Upfront - Apricus Biosciences Announces Removal of Auditor's "Going Concern" Opinion From Its 2010 Form 10-K and Increased Cash Reserves

09/12 16:21 Upfront - VELCADE(R) (bortézomib) administré par voie sous-cutanée affiche un taux de réponse et un profil d'innocuité comparables à l'administration par voie intraveineuse dans le traitement de la rechute du myélome multiple

22/06 17:41 Upfront - IBt - International Brachytherapy s.a. : Russie - Joint-venture - Développement Signature de deux contrats

31/03 17:40 Upfront - VIVALIS annonce ses résultats pour l'exercice 2008 et ses perspectives stratégiques